MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-21-0002214
Market Cap
₹68.19 Cr
SHELTER · BSE
Share Price
₹42.52
+4.99% today
Revenue
₹73.13 Cr
FY 2025-26 · +44.4% YoY
EBITDA
₹12.74 Cr
Margin 17.4%
Net Profit
₹9.03 Cr
FY 2025-26 · +24.6% YoY
P/E (TTM)
7.4x
P/B 0.9x
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹17.3 Cr
Issued & subscribed
About Shelter Pharma Limited
Data last updated:
Shelter Pharma Limited is a public limited company based in Himatnagar, Gujarat, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 12 October 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24233GJ2007PLC051956. Its GSTIN is 24AALCS3158D1ZG (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 543963.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹17.3 Cr. It is led by directors including Mustaqim Nisarahmed Sabugar (Managing Director) and Shakil Nisarahmed Sabugar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Shelter Nagar Nr. S. T. Bus Stand, Himmatnagar, Gujarat, India – 383001.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹73.13 Cr, a growth of 44.4% compared to the previous year. For the same year it recorded a net profit of ₹9.03 Cr (net margin 12.3%) and EBITDA of ₹12.74 Cr (EBITDA margin 17.4%). The net worth stands at ₹76.63 Cr (up 79.4% YoY). Total assets are valued at ₹77.5 Cr (up 76.9% YoY).
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Shelter. As per MCA filings, the company has open charges of ₹58 Lakh and satisfied charges of ₹5 Cr on record. Court records list 15 cases involving the company, including 11 filed by the company and 4 filed against it; 3 cases are pending. The company has 23 deals on record (21 market trades, 1 ipo, 1 funding round), with disclosed funding of ₹3.6 Cr; the latest was in January 2026. Its 4 peer companies in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Sheetal Medicare Products Limited with revenue of ₹52.04 Cr. The company has 2 MSME Form 1 returns on record between 2019 and 2023, listing 12 overdue payments to 9 micro and small suppliers.
Shelter Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-21-0002214). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shelter.co.in.
Company details
CIN L24233GJ2007PLC051956
Registration Number 051956
Incorporation Date 12 October 2007
ROC Ahmedabad
Listing Status Listed - Listed on BSE (543963)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-21-0002214
CIN history
Shelter Pharma has one previous CIN (Corporate Identification Number): U24233GJ2007PLC051956. The current CIN is L24233GJ2007PLC051956, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24233GJ2007PLC051956 | Current |
| U24233GJ2007PLC051956 | Previous |
Key People
Mustaqim Nisarahmed Sabugar Managing Director Shakil Nisarahmed Sabugar Whole-Time Director Parvezbanu Mohamed Rafiq Idariya Director Recognitions & Rankings of Shelter Pharma
Contact details
Shelter Pharma Limited's registered office is in Himmatnagar, Gujarat. Its website is shelter.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShelter Nagar Nr. S. T. Bus Stand, Himmatnagar, Gujarat, India – 383001
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Shelter Pharma Limited, buy the company report.
Comprehensive company report
Shelter Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Shelter Pharma operates one associated brand: Shelter. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Shelter is recognized as a trusted manufacturer of human and veterinary healthcare medicines in India. | shelter.co.in |
Business activity
The main business activity of Shelter Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shelter Pharma Limited, buy the company report.
Financials of Shelter Pharma Limited
FY 2025-26 filings availableShelter Pharma Limited reported revenue of ₹73.13 Cr (up 44.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹73.13 Cr
+44.4% YoY
EBITDA
₹12.74 Cr
+26.4% YoY
Profit After Tax
₹9.03 Cr
+24.6% YoY
Net Worth
₹76.63 Cr
+79.4% YoY
Total Assets
₹77.50 Cr
+76.9% YoY
Total Debt
₹0.80 Cr
-23.1% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 73.13 | 50.66 | 40.02 | 36.15 | 30.06 | 22.48 | 30.07 |
| Revenue growth | +44.4% | +26.6% | +10.7% | +20.3% | +33.7% | -25.2% | - |
| EBITDA | 12.74 | 10.08 | 8.77 | 7.17 | 3.06 | 0.17 | 0.25 |
| EBITDA margin | +17.4% | +19.9% | +21.9% | +19.8% | +10.2% | +0.8% | +0.8% |
| Profit before tax | 12.23 | 9.69 | 8.26 | 6.98 | 2.81 | 0.04 | 0.12 |
| Net profit | 9.03 | 7.25 | 6.18 | 5.92 | 2.06 | 0.02 | 0.09 |
| Net profit margin | +12.4% | +14.3% | +15.4% | +16.4% | +6.9% | +0.1% | +0.3% |
| EPS (₹) | 5.43 | 6.26 | 5.36 | 6.72 | 42.54 | 0.85 | 1.77 |
| Balance sheet | |||||||
| Total assets | 77.50 | 43.82 | 36.44 | 16.38 | 8.97 | 7.20 | 7.30 |
| Net worth | 76.63 | 42.72 | 35.82 | 14.55 | 8.80 | 7.11 | 6.98 |
| Total debt | 0.80 | 1.04 | 0.58 | 1.78 | 0.13 | 0.00 | 0.24 |
| Cash & bank | 1.08 | 3.42 | 5.04 | 0.43 | 0.10 | 0.37 | 0.14 |
| Net working capital | 48.33 | 28.76 | 28.24 | 13.77 | 6.06 | 4.98 | 4.84 |
| Cash flow | |||||||
| Cash from operations | (12.48) | 5.42 | (1.96) | 0.00 | 0.52 | (0.28) | (0.27) |
| Cash from investing | (14.55) | (7.13) | (4.43) | 0.11 | (0.85) | 0.03 | 0.29 |
| Cash from financing | 24.69 | 0.09 | 11.01 | 0.21 | 0.06 | 0.48 | 0.00 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 73.13 | 50.66 | 40.02 | 36.15 | 30.06 | 22.48 | 30.07 |
| Revenue growth | +44.4% | +26.6% | +10.7% | +20.3% | +33.7% | -25.2% | - |
| Other income | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total expenses | 60.39 | 40.58 | 31.25 | 28.98 | 27.00 | 22.31 | 29.82 |
| Employee cost | 1.13 | 1.22 | 0.63 | 0.45 | 0.35 | 0.33 | 0.39 |
| EBITDA | 12.74 | 10.08 | 8.77 | 7.17 | 3.06 | 0.17 | 0.25 |
| EBITDA margin | +17.4% | +19.9% | +21.9% | +19.8% | +10.2% | +0.8% | +0.8% |
| Depreciation | 0.41 | 0.27 | 0.25 | 0.16 | 0.17 | 0.12 | 0.13 |
| Interest | 0.12 | 0.13 | 0.26 | 0.03 | 0.08 | 0.02 | 0.01 |
| Profit before tax | 12.23 | 9.69 | 8.26 | 6.98 | 2.81 | 0.04 | 0.12 |
| Tax | 3.20 | 2.44 | 2.08 | 1.78 | 0.75 | 0.02 | 0.03 |
| Net profit | 9.03 | 7.25 | 6.18 | 5.92 | 2.06 | 0.02 | 0.09 |
| Net profit margin | +12.4% | +14.3% | +15.4% | +16.4% | +6.9% | +0.1% | +0.3% |
| EPS (₹) | 5.43 | 6.26 | 5.36 | 6.72 | 42.54 | 0.85 | 1.77 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 16.61 | 11.56 | 11.56 | 7.74 | 0.48 | 0.48 | 0.45 |
| Reserves & surplus | 56.05 | 31.16 | 24.26 | 6.81 | 8.32 | 6.63 | 6.53 |
| Shareholders' funds (net worth) | 76.63 | 42.72 | 35.82 | 14.55 | 8.80 | 7.11 | 6.98 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.80 | 1.04 | 0.58 | 1.78 | 0.13 | 0.00 | 0.24 |
| Total debt | 0.80 | 1.04 | 0.58 | 1.78 | 0.13 | 0.00 | 0.24 |
| Total liabilities | 77.50 | 43.82 | 36.44 | 16.38 | 8.97 | 7.20 | 7.30 |
| Assets | |||||||
| Gross block | 9.94 | 8.36 | 6.38 | 4.40 | 3.17 | 3.12 | 3.11 |
| Net block | 7.14 | 5.97 | 4.25 | 2.52 | 1.45 | 1.57 | 1.77 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 |
| Investments | 0.68 | 0.68 | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 |
| Inventories | 24.44 | 12.90 | 9.93 | 7.96 | 5.67 | 4.02 | 4.31 |
| Sundry debtors | 11.81 | 9.47 | 8.85 | 8.19 | 1.61 | 0.76 | 0.61 |
| Cash & bank balances | 1.08 | 3.42 | 5.04 | 0.43 | 0.10 | 0.37 | 0.14 |
| Loans & advances | 17.73 | 7.49 | 5.90 | 2.13 | 2.45 | 2.73 | 3.01 |
| Total current assets | 55.06 | 33.28 | 29.72 | 18.71 | 9.83 | 7.88 | 8.07 |
| Total current liabilities | 6.73 | 4.52 | 1.48 | 4.94 | 3.77 | 2.90 | 3.23 |
| Net working capital | 48.33 | 28.76 | 28.24 | 13.77 | 6.06 | 4.98 | 4.84 |
| Total assets | 77.50 | 43.82 | 36.44 | 16.38 | 8.97 | 7.20 | 7.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 3.42 | 5.04 | 0.43 | 0.10 | 0.37 | 0.14 | 0.12 |
| Net cash from operating activities | (12.48) | 5.42 | (1.96) | 0.00 | 0.52 | (0.28) | (0.27) |
| Net cash from investing activities | (14.55) | (7.13) | (4.43) | 0.11 | (0.85) | 0.03 | 0.29 |
| Net cash from financing activities | 24.69 | 0.09 | 11.01 | 0.21 | 0.06 | 0.48 | 0.00 |
| Net change in cash | (2.34) | (1.62) | 4.61 | 0.33 | (0.27) | 0.23 | 0.02 |
| Closing cash | 1.08 | 3.42 | 5.04 | 0.43 | 0.10 | 0.37 | 0.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +44.4% | +26.6% | +10.7% | +20.3% | +33.7% | -25.2% | - |
| EBITDA growth | +26.4% | +14.9% | +22.3% | +134.3% | +1700.0% | -32.0% | - |
| PBT growth | +26.2% | +17.3% | +18.3% | +148.4% | +6925.0% | -66.7% | +71.4% |
| Net income growth | +24.6% | +17.3% | +4.4% | +187.4% | - | -77.8% | - |
| Revenue CAGR (3Y) | +26.5% | +19.0% | +21.2% | +6.3% | +0.1% | -7.2% | - |
| EBITDA CAGR (3Y) | +21.1% | +48.8% | +272.3% | +206.1% | - | +4.3% | - |
| Profitability & leverage | |||||||
| Net income margin | +12.4% | +14.3% | +15.4% | +14.4% | +6.9% | +0.1% | +0.3% |
| Return on capital employed | - | +25.0% | +33.5% | +68.1% | +40.5% | +1.3% | +1.9% |
| Return on net worth | - | +18.9% | +25.6% | +55.3% | +29.4% | +0.7% | +1.4% |
| Debt / equity | - | 0.02 | 0.05 | 0.09 | 0.01 | 0.02 | 0.04 |
| Long-term debt / equity | - | 0.02 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.97 | 1.33 | 3.05 | 0.43 | 2.77 | 40.00 | 8.33 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 7.88 | 8.99 | 12.71 | 13.63 | 10.55 | 14.46 |
| Inventory turnover | - | 4.44 | 4.47 | 5.30 | 6.20 | 5.40 | 6.98 |
| Debtors turnover | - | 5.53 | 4.70 | 7.38 | 25.37 | 32.82 | 49.30 |
| EPS (₹) | 5.43 | 6.26 | 5.36 | 6.72 | 42.54 | 0.85 | 1.77 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 43.18 | 36.14 | 30.17 | 17.57 | 162.45 | 127.48 | 131.03 |
To see the full year-wise statements and ratios of Shelter Pharma Limited, buy the company report.
Board of directors of Shelter Pharma Limited
Shelter Pharma has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvezbanu Mohamed Rafiq Idariya Also directs: Shelter Pharmacy Private Limited | Director | 13 Oct 2021 | 5 Years 0 Months | Current |
| Shakil Nisarahmed Sabugar | Whole-Time Director | 12 Oct 2007 | 19 Years 0 Months | Current |
| Mustaqim Nisarahmed Sabugar | Managing Director | 12 Oct 2007 | 19 Years 0 Months | Current |
| Mosinkhan Gafarkhan Pathan | Director | 23 Feb 2023 | 3 Years 8 Months | Current |
| Riyazahmed Abdulrauf Sabugar | Director | 23 Feb 2023 | 3 Years 8 Months | Current |
| Vinita Shivraj Gadhavi | Director | 31 Jul 2026 | 0 Years 2 Months | Current |
Peer comparison
Shelter Pharma Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shelter Pharma Limitedthis company | ₹73.13 Cr (FY 2026) | ₹9.03 Cr | 12.3% | 44.4% | Himatnagar, Gujarat, India | |
| Sheetal Medicare Products Limited | ₹52.04 Cr (FY 2025) | 17.0% | Wada, Maharashtra, India | |||
| SKM Siddha and Ayurvedha Company (India) Private Limited | ₹51.27 Cr (FY 2024) | 10.0% | Erode, Tamil Nadu, India | |||
| Goodcare Pharma Pvt Ltd | ₹49.94 Cr (FY 2024) | 61.0% | Kolkata, West Bengal, India | |||
| Avimee Herbal Private Limited | ₹49.51 Cr (FY 2024) | 71.0% | Surat, Gujarat, India |
To see the full peer comparison of Shelter Pharma Limited, buy the company report.
Auditor
Shelter Pharma Limited is audited by Mendajiwala & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mendajiwala & Co. | FY 2023 | 0135065W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 45.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 55.00%.
Sep 2026
QUARTER
45.00% Promoters
55.00% Retail & Others
Promoter holding - history
Now 45.00% · Sep 2026High 52.30% · Dec 2025Low 45.00% · Sep 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 45.00% | 52.30% | 52.30% | 52.30% |
| Public | 55.00% | 47.70% | 47.70% | 47.70% |
Charges & borrowings
Open charges
₹58 Lakh
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Mar 2024 | 100881244 | Others | ₹58 Lakh | Open | |
| 11 Jun 2010 | 10232854 | Axis Bank Limited | ₹2 Cr | Satisfied | |
| 20 Apr 2009 | 10152259 | Axis Bank Limited | ₹1.5 Cr | Satisfied | |
| 27 Mar 2009 | 10152257 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
To see the full charge records of Shelter Pharma Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Shelter Pharma Limited has 23 deals on record (21 market trades, 1 ipo, 1 funding round), with disclosed funding of ₹3.6 Cr; the latest was in January 2026.
Total deals
23
Market trades
21
IPO
1
Funding round
1
Disclosed funding
₹3.6 Cr
Deals on record (5 of 23)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2024 | Market trade | ₹2.41 Cr | Buyer: Liesha Corporation Private Limited , 3 individuals Seller: Liesha Corporation Private Limited , an individual |
| Nov 2023 | Market trade | ₹58.4 Lakh | Buyer: Liesha Corporation Private Limited Seller: Liesha Corporation Private Limited |
| Nov 2023 | Market trade | ₹1.26 Cr | Seller: Yuga Stocks & Commodities Private Limited , an individual |
| Nov 2023 | Market trade | ₹33.9 Lakh | Buyer: Yuga Stocks & Commodities Private Limited |
| Aug 2023 | Market trade | ₹81.1 Lakh | Buyer: Viney Equity Market LLP , an individual Seller: Gretex Share Broking Limited |
To see the full deal history of Shelter Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Shelter Pharma Limited has 15 court cases on record: 11 filed by Shelter Pharma, 4 filed against it. 3 cases are pending and 12 are disposed.
Total cases
15
Filed by the company
11
Filed against the company
4
Pending
3
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 4 | 3 |
| High courts | 3 | 0 | 0 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (CR.RA) | Filed by the company against Shree Azad Transport Co. Ltd. Administrator Cum Branch Manager, Nagendrsing Harivanshsing Rajput and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR A) | Filed by the company against Azad Transport Co. Ltd Administrator Cum Branch Manager Nagendrasing Harivanshsing Rajput and 1 other | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against Bharat Sanchar Nigam Limited and 1 other | Disposed |
| District court, Sabarkantha at Himmatnagar, Gujarat | Court case (CR A) | Filed by the company against Shri Brijlal Meena, Asst. Commissioner of Income Tax | Pending |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed by the company against individuals | Pending |
To see the full case history of Shelter Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Shelter Pharma Limited has 2 MSME Form 1 returns on record between 2019 and 2023, listing 12 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dipna Pharmachem Limited | |||
| an individual supplier | |||
| Padmavati Blow Plastic | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Shelter Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Shelter Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AALCS3158D1ZG | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shelter Pharma Limited, buy the company report.
Recent activity
Shelter Pharma Limited has 9 board changes on record since 2007: 6 appointments and 3 cessations. The latest: Vinita Shivraj Gadhavi was appointed as Director on 31 Jul 2026.
Appointed
Vinita Shivraj Gadhavi was appointed as Director.
Filing
Shelter Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
AGM
Shelter Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.58 Cr with Charge ID 100881244 was registered on 12 Mar 2024.
Appointed
Mosinkhan Gafarkhan Pathan was appointed as Director.
Appointed
Riyazahmed Abdulrauf Sabugar was appointed as Director.
Ceased
Nisarahmed Abdulnabi Sabugar ceased to be Whole-Time Director.
Appointed
Parvezbanu Mohamed Rafiq Idariya was appointed as Director.
Charges
A charge registered on 11 Jun 2010 via Charge ID 10232854 with Axis Bank Limited was fully satisfied on 19 Aug 2016.
Ceased
Mohammedrafiq Gulamnabi Shaikh ceased to be CFO.
Ceased
Bala Nayar Raman ceased to be Nominee Director.
Charges
A charge registered on 20 Apr 2009 via Charge ID 10152259 with Axis Bank Limited was fully satisfied on 15 Jul 2010.
7 earlier events are in the company report.
News
Frequently asked questions
Shelter Pharma is an active public limited company based in Himatnagar, Gujarat, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 12 October 2007 (19+ years old) and is registered under CIN L24233GJ2007PLC051956. Listed on BSE: 543963.
Shelter Pharma reported revenue of ₹73.13 Cr for FY 2025-26 (up 44.4% YoY) based on standalone financials.
Shelter Pharma has 6 current directors:
- Mustaqim Nisarahmed Sabugar - Managing Director
- Shakil Nisarahmed Sabugar - Whole-Time Director
- Parvezbanu Mohamed Rafiq Idariya - Director
- Mosinkhan Gafarkhan Pathan - Director
- Riyazahmed Abdulrauf Sabugar - Director
- Vinita Shivraj Gadhavi - Director
The latest financial statements of Shelter Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shelter Pharma is 24AALCS3158D1ZG, registered in Gujarat.
The CIN (Corporate Identification Number) of Shelter Pharma is L24233GJ2007PLC051956. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Shelter Pharma is a listed company as per MCA records. Its shares are listed on BSE (code: 543963).
Shelter Pharma has 15 court cases on record: 11 filed by the company and 4 filed against it. 3 are pending. Most are in the district courts.
Shelter Pharma was incorporated on 12 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Shelter Pharma has 23 deals on record (21 market trades, 1 ipo, 1 funding round), with disclosed funding of ₹3.6 Cr; the latest was in January 2026.
The peers of Shelter Pharma by revenue are Sheetal Medicare Products Limited, SKM Siddha and Ayurvedha Company (India) Private Limited, Goodcare Pharma Pvt Ltd, Avimee Herbal Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vinita Shivraj Gadhavi was appointed as Director on 31 Jul 2026. Mosinkhan Gafarkhan Pathan was appointed as Director on 23 Feb 2023. Riyazahmed Abdulrauf Sabugar was appointed as Director on 23 Feb 2023. Shelter Pharma has 9 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages